default author photo

Joseph Katende Ssebwana

London School of Hygiene & Tropical Medicine - Uganda Research Unit

SCHOLARLY PAPERS

3

DOWNLOADS

216

TOTAL CITATIONS

3

Scholarly Papers (3)

1.

Safety and Immunogenicity of a Modified Self-Amplifying Ribonucleic Acid (saRNA) Vaccine Encoding SARS-CoV-2 Spike Glycoprotein in SARS-CoV-2 Seronegative and Seropositive Ugandan Individuals

Number of pages: 60 Posted: 19 Feb 2025
London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Imperial College London - Department of Infectious Disease, Government of Uganda - Uganda Virus Research Institute (UVRI), London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, MRC/UVRI & LSHTM Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease, Imperial College London - Department of Infectious Disease and London School of Hygiene & Tropical Medicine - Uganda Research Unit
Downloads 113 (630,858)
Citation 3

Abstract:

Loading...

Self-amplifying RNA (saRNA) vaccine, SARS-CoV-2 immunogenicity, COVID-19 Vaccination in Africa, Neutralising antibody responses, Spike-specific IgG antibodies, Vaccine safety and reactogenicity, Seronegative vs. seropositive immune response

2.

Two Decades Later: Long-Term Multisystem Sequelae and Subclinical Organ Dysfunction in Sudan Ebola Virus (SUDV) Survivors. Persistent Sequelae in Sudv Survivors after 25 Years

Number of pages: 34 Posted: 28 May 2025
Government of Uganda - Uganda Virus Research Institute (UVRI), London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Government of Uganda - Uganda Virus Research Institute (UVRI), Government of Uganda - Uganda Virus Research Institute (UVRI), Government of Uganda - Uganda Virus Research Institute (UVRI), Government of Uganda - Uganda Virus Research Institute (UVRI), London School of Hygiene & Tropical Medicine - Uganda Research Unit, Independent, Government of Uganda - Uganda Virus Research Institute (UVRI), London School of Hygiene & Tropical Medicine - Uganda Research Unit and London School of Hygiene & Tropical Medicine - Uganda Research Unit
Downloads 66 (916,100)

Abstract:

Loading...

Sudan ebolavirus, Long-term sequelae, Post EVD syndrome, Ebola survivors, Subclinical dysfunction, Psychosocial resilience, Viral hemorrhagic fever

3.

Resilience and Residuals Beyond Containment: The Hidden Burden of Bundibugyo Ebola Virus Survivorship Sixteen Years On

Number of pages: 34 Posted: 20 Jun 2025
Government of Uganda - Uganda Virus Research Institute (UVRI), London School of Hygiene & Tropical Medicine - Uganda Research Unit, Government of Uganda - Uganda Virus Research Institute (UVRI), Government of Uganda - Uganda Virus Research Institute (UVRI), London School of Hygiene & Tropical Medicine - Uganda Research Unit, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Government of Uganda - Uganda Virus Research Institute (UVRI), Government of Uganda - Uganda Virus Research Institute (UVRI), Government of Uganda - Uganda Virus Research Institute (UVRI), Independent, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Government of Uganda - Uganda Virus Research Institute (UVRI) and London School of Hygiene & Tropical Medicine - Uganda Research Unit
Downloads 37 (1,263,436)

Abstract:

Loading...

Bundibugyo ebolavirus, Ebola virus disease survivors, Post-Ebola syndrome, Long-term viral sequelae, Immunometabolic findings, Survivorship care models, Epidemic preparedness